Salta alla navigazione principale Salta alla ricerca Salta al contenuto principale

WWP2 regulates pathological cardiac fibrosis by modulating SMAD2 signaling

  • H. Chen
  • , A. Moreno-Moral
  • , Francesco Pesce
  • , N. Devapragash
  • , M. Mancini
  • , E. L. Heng
  • , M. Rotival
  • , P. K. Srivastava
  • , N. Harmston
  • , K. Shkura
  • , O. J. L. Rackham
  • , Yu W. -P.
  • , Sun X. -M.
  • , N. G. Z. Tee
  • , E. L. S. Tan
  • , P. J. R. Barton
  • , L. E. Felkin
  • , E. Lara-Pezzi
  • , G. Angelini
  • , C. Beltrami
  • M. Pravenec, S. Schafer, L. Bottolo, N. Hubner, C. Emanueli, S. A. Cook, E. Petretto*
*Autore corrispondente per questo lavoro
  • Duke-National University of Singapore Medical School
  • Institut Pasteur Paris
  • Imperial College London
  • Centro Nacional de Investigaciones Cardiovasculares
  • Southmead Hospital
  • Czech Academy of Sciences
  • National Heart Centre Singapore
  • University of Cambridge
  • Alan Turing Institute
  • Charité – Universitätsmedizin Berlin
  • German Centre for Cardiovascular Research
  • Berlin Institute of Health
  • Max Delbrück Center for Molecular Medicine in the Helmholtz Association
  • Royal Brompton and Harefield Trust

Risultato della ricerca: Contributo in rivistaArticolo

Abstract

Cardiac fibrosis is a final common pathology in inherited and acquired heart diseases that causes cardiac electrical and pump failure. Here, we use systems genetics to identify a pro-fibrotic gene network in the diseased heart and show that this network is regulated by the E3 ubiquitin ligase WWP2, specifically by the WWP2-N terminal isoform. Importantly, the WWP2-regulated pro-fibrotic gene network is conserved across different cardiac diseases characterized by fibrosis: human and murine dilated cardiomyopathy and repaired tetralogy of Fallot. Transgenic mice lacking the N-terminal region of the WWP2 protein show improved cardiac function and reduced myocardial fibrosis in response to pressure overload or myocardial infarction. In primary cardiac fibroblasts, WWP2 positively regulates the expression of pro-fibrotic markers and extracellular matrix genes. TGFβ1 stimulation promotes nuclear translocation of the WWP2 isoforms containing the N-terminal region and their interaction with SMAD2. WWP2 mediates the TGFβ1-induced nucleocytoplasmic shuttling and transcriptional activity of SMAD2.
Lingua originaleInglese
pagine (da-a)1-1
Numero di pagine1
RivistaNature Communications
Volume10
Numero di pubblicazione1
DOI
Stato di pubblicazionePubblicato - 2019

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

  1. SDG 3 - Salute e benessere
    SDG 3 Salute e benessere

All Science Journal Classification (ASJC) codes

  • Chimica Generale
  • Biochimica, Genetica, Biologia Molecolare Generali
  • Multidisciplinare
  • Fisica e Astronomia Generali

Keywords

  • Fibrosis

Fingerprint

Entra nei temi di ricerca di 'WWP2 regulates pathological cardiac fibrosis by modulating SMAD2 signaling'. Insieme formano una fingerprint unica.

Cita questo